Oncology Views & Analysis

Views & Analysis

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Marc Moodley has worked at Sanofi since 2018 and is the new medical head, UK and Ireland for the company’s Genzyme unit.

Views & Analysis

Pfizer and the UK cancer landscape: the pharmaphorum podcast

Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK cancer landscape.

Views & Analysis

Q&A: Avacta’s Amrik Basran on immunotherapy

Dr Amrik Basran from Avacta explains the current state of cancer immunotherapy and the challenges of moving into combinations of these innovative treatments.

Views & Analysis

Demonstrating the value of RWE

A new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional trials.

Views & Analysis

QandA-Drapers-Jenna-Balestrini-on-the-future-of-CAR-T

Q&A: Draper’s Jenna Balestrini on the future of CAR-T

As exciting as CAR-T is, there are still myriad challenges preventing it from reaching its full potential.

Views & Analysis

The state of personalised medicine in 2019

Things are good, and they’re getting better.

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Pfizer and the UK cancer landscape: the pharmaphorum podcast

Q&A: Avacta’s Amrik Basran on immunotherapy

Demonstrating the value of RWE

Q&A: Draper’s Jenna Balestrini on the future of CAR-T

The state of personalised medicine in 2019

Activist investor renews its criticism of Novavax

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks